Natural compound found in broccoli reawakens the function of potent tumor suppressor
(Beth Israel Deaconess Medical Center) Long associated with decreased risk of cancer, broccoli and other cruciferous vegetables -- the family of plants that also includes cauliflower, cabbage, collard greens, Brussels sprouts and kale -- contain a molecule that inactivates a gene known to play a role in a variety of common human cancers. A new study demonstrates that targeting the gene, known as WWP1, with the ingredient found in broccoli suppressed tumor growth in cancer-prone lab animals. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2019 Category: Cancer & Oncology Source Type: news

The Lancet Gastroenterology & Hepatology: Colorectal cancer incidence on the rise among young adults in several high-income countries
(The Lancet) The incidence of colon and rectal cancer in adults younger than 50 years has increased substantially over the latest available 10-year period in several high-income countries, going against a decline or stabilisation trend in the incidence of colorectal cancers within the overall populations of high-income countries. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2019 Category: Cancer & Oncology Source Type: news

Case Comprehensive Cancer Center awarded nearly $9 million to expand access to clinical trials
(Case Western Reserve University) Case Comprehensive Cancer Center has been selected, once again, as a Lead Academic Participating Site by the National Cancer Institute. The renewal comes with a six-year, $8.9 million grant that will enable the center to provide patients with additional access to clinical trials through the National Clinical Trials Network. In this renewal, NCI is committed to improving the resources provided for each patient to cover research costs at levels linked to the complexity of the clinical trial. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2019 Category: Cancer & Oncology Source Type: news

Improving health outcomes with a little help from our friends -- and artificial intelligence
(Medical University of South Carolina) The National Academy of Medicine has called for physicians to document social isolation in the electronic health record (EHR), because it can affect health outcomes. However, social isolation cannot be entered as coded data in current EHRs but only mentioned in clinical notes, which have historically been unintelligible to computers. Medical University of South Carolina investigators have trained natural language processing software to search clinical notes and identify socially isolated patients with 90% accuracy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2019 Category: Cancer & Oncology Source Type: news

Scientists develop technology to capture tumor cells
(University of Georgia) Instead of searching for a needle in a haystack, what if you were able to sweep the entire haystack to one side, leaving only the needle behind? That's the strategy researchers in the University of Georgia College of Engineering followed in developing a new microfluidic device that separates elusive circulating tumor cells (CTCs) from a sample of whole blood. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2019 Category: Cancer & Oncology Source Type: news

Partial breast irradiation effective treatment option for low-risk breast cancer
(MediaSource) Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2019 Category: Cancer & Oncology Source Type: news

First-Line Therapy for Metastatic RCC Remains Controversial Amid New Approvals
The bar for the standard of care among patients with advanced renal cell carcinoma is set high as various promising combination therapies recently received FDA approval. (Source: CancerNetwork)
Source: CancerNetwork - May 16, 2019 Category: Cancer & Oncology Authors: Christina Bennett, MS Source Type: news

Assessing the Benefit of Trebananib in Advanced Ovarian Cancer
Researchers tested the angiogenesis inhibitor trebananib combined with the standard of care in patients with advanced ovarian cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 16, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Marine organisms hold promise for treating triple negative breast cancer
(Florida Atlantic University) More than 50 percent of cancer drugs currently used have originated from natural products. Researchers have received $801,000 from the Florida Department of Health for a project to investigate the use of marine natural compounds as potential treatments of triple negative breast cancers. This form of breast cancer, which represents about 12 percent of breast cancers diagnosed in the United States, can be very aggressive and easily spread to other organs, particularly the brain and the lungs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 16, 2019 Category: International Medicine & Public Health Source Type: news

CRISPR catches out critical cancer changes
(Wellcome Trust Sanger Institute) In the first large-scale analysis of cancer gene fusions, researchers at the Wellcome Sanger Institute and their collaborators used CRISPR to uncover which gene fusions are critical for the growth of cancer cells. The team also identified a new gene fusion that presents a novel drug target for multiple cancers, including brain and ovarian cancers. The results give more certainty for the use of specific gene fusions to diagnose and guide the treatment of patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2019 Category: Cancer & Oncology Source Type: news

Cancer drugs promote stem cell properties of colorectal cancer
(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Mannheim University Medical Center have now discovered that a certain group of cancer drugs (MEK Inhibitors) activates the cancer-promoting Wnt signalling pathway in colorectal cancer cells. This can lead to the accumulation of tumor cells with stem cell characteristics that are resistant to many therapies and can lead to relapses. The researchers thus provide a possible explanation for why these drugs are not effective in colorectal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 16, 2019 Category: Cancer & Oncology Source Type: news

Cancer warning - do your gums look like this? The hidden signs in your mouth
CANCER symptoms vary depending on which part of the body is affected by a tumour. You could be at risk of deadly leukaemia if you notice this hidden sign in your mouth. Do your gums look like this? (Source: Daily Express - Health)
Source: Daily Express - Health - May 16, 2019 Category: Consumer Health News Source Type: news

New dawn in cancer war: Scientists to develop revolutionary drugs to stop resistant tumours
Christine O’Connell was nearing five years in remission for breast cancer when she suffered a seizure while cycling in London last February. Now she is being treated with the new generation drugs. (Source: the Mail online | Health)
Source: the Mail online | Health - May 16, 2019 Category: Consumer Health News Source Type: news

Cancer Researchers to Rock Buddy Guy ’s Legends for One Night Only
Nobel Prize-winning cancer researcher James P. Allison, PhD, and The CheckPoints, the Society for Immunotherapy of Cancer’s (SITC) house band, return to Buddy Guy’s Legends for a performance on June...(PRWeb May 16, 2019)Read the full story at https://www.prweb.com/releases/cancer_researchers_to_rock_buddy_guys_legends_for_one_night_only/prweb16317549.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 16, 2019 Category: Pharmaceuticals Source Type: news

Machine Learning for Automated Immune Profiling and Tumor Morphology...
While traditional TNM staging helps with the clinical treatment decision for patients with muscle-invasive bladder cancer (MIBC), it may not adequately encompass the complex and dynamic behavior of...(PRWeb May 16, 2019)Read the full story at https://www.prweb.com/releases/machine_learning_for_automated_immune_profiling_and_tumor_morphology_analysis_on_if_images_new_webinar_hosted_by_xtalks/prweb16316627.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - May 16, 2019 Category: Pharmaceuticals Source Type: news

Low-Fat Diet Could Be a Weapon Against Breast Cancer
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - May 16, 2019 Category: Cancer & Oncology Source Type: news

Low-Fat Diet Could Be a Weapon Against Breast Cancer
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - May 16, 2019 Category: Cancer & Oncology Source Type: news

Low-fat diet may cut risk of dying from breast cancer, study finds
Doctors say the results show a way women might improve their odds of survival (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 16, 2019 Category: Consumer Health News Source Type: news

15.05.19: Not intended for U.S. and UK Media - Annual Meeting of the American Society of Clinical Oncology (ASCO) 2019
New data for larotrectinib show overall response rates of 94% in children and 76% in adults with TRK fusion cancer; clinical benefit demonstrated in patients with primary central nervous system tumors and brain metastasesIn children with TRK fusion cancer (n=34), the overall response rate (ORR) was 94% and durable, with median duration of response (DOR) not reached / In adults with TRK fusion cancer (n=74), the ORR was 76% and durable, with median DOR not reached / In evaluable patients with brain metastases (n=5), ORR was 60% / Improvements in quality of life were shown with larotrectinib treatment in both children and ad...
Source: Bayer IR Newsfeed: Events - May 16, 2019 Category: Pharmaceuticals Source Type: news

Lower-fat diet reduces women’s risk of dying from breast cancer, study says
Women who followed a lower-fat diet rich in fruits, vegetables and grains had a lower risk of dying of breast cancer than those on a higher-fat diet, according to the results of major study released W... (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - May 16, 2019 Category: Consumer Health News Authors: Laurie McGinley Source Type: news

Janssen to Present Data from Robust Oncology Portfolio and Pipeline at the 2019 ASCO Annual Meeting, Including Best of ASCO Selections
(Source: Johnson and Johnson)
Source: Johnson and Johnson - May 16, 2019 Category: Pharmaceuticals Source Type: news

Scientists in new push to control cancer before curing it
Cancer scientists in Britain are launching what they call the world's first "Darwinian" drug development program in a bid to get ahead of cancer's ability to become resistant to even the newest treatments and recur in many patients. (Source: Reuters: Health)
Source: Reuters: Health - May 16, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

New war on cancer aims at longterm survival, not cure
Scientists want to ‘take away the fear’ by halting mutation of cells, even in advanced casesLeading scientists are embarking on a new war against cancer, aimed not necessarily at curing it but at turning it into a condition that people can live with.The world-renownedInstitute of Cancer Research is launching what it calls the first-ever “Darwinian” cancer programme. Just as with antibiotics, they say, cancers can evolve to become resistant to the drugs used to treat them. Cancer cells that are not killed off by chemotherapy or even immunotherapy will eventually mutate and adapt to form new tumours. ...
Source: Guardian Unlimited Science - May 16, 2019 Category: Science Authors: Sarah Boseley Health editor Tags: Cancer research Health Medical research Science Artificial intelligence (AI) Drug resistance Drugs Source Type: news

UK cancer programme to target treatment resistance
Institute of Cancer Research centre aims to redirect process of cancer evolution (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 16, 2019 Category: Pharmaceuticals Source Type: news

Mechanism of allosteric modulation of P-glycoprotein by transport substrates and inhibitors
The ATP-binding cassette subfamily B member 1 (ABCB1) multidrug transporter P-glycoprotein plays a central role in clearance of xenobiotics in humans and is implicated in cancer resistance to chemotherapy. We used double electron electron resonance spectroscopy to uncover the basis of stimulation of P-glycoprotein adenosine 5'-triphosphate (ATP) hydrolysis by multiple substrates and illuminate how substrates and inhibitors differentially affect its transport function. Our results reveal that substrate-induced acceleration of ATP hydrolysis correlates with stabilization of a high-energy, post-ATP hydrolysis state characteri...
Source: ScienceNOW - May 16, 2019 Category: Science Authors: Dastvan, R., Mishra, S., Peskova, Y. B., Nakamoto, R. K., Mchaourab, H. S. Tags: Biochemistry reports Source Type: news

Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway
Activation of tumor suppressors for the treatment of human cancer has been a long sought, yet elusive, strategy. PTEN is a critical tumor suppressive phosphatase that is active in its dimer configuration at the plasma membrane. Polyubiquitination by the ubiquitin E3 ligase WWP1 (WW domain–containing ubiquitin E3 ligase 1) suppressed the dimerization, membrane recruitment, and function of PTEN. Either genetic ablation or pharmacological inhibition of WWP1 triggered PTEN reactivation and unleashed tumor suppressive activity. WWP1 appears to be a direct MYC (MYC proto-oncogene) target gene and was critical for MYC-drive...
Source: ScienceNOW - May 16, 2019 Category: Science Authors: Lee, Y.-R., Chen, M., Lee, J. D., Zhang, J., Lin, S.-Y., Fu, T.-M., Chen, H., Ishikawa, T., Chiang, S.-Y., Katon, J., Zhang, Y., Shulga, Y. V., Bester, A. C., Fung, J., Monteleone, E., Wan, L., Shen, C., Hsu, C.-H., Papa, A., Clohessy, J. G., Teruya-Felds Tags: Genetics, Medicine, Diseases, Online Only r-articles Source Type: news

Swarms of bugs, missing data plague firms now making heart drug
Last month, the FDA posted a list of 43 versions of valsartan and similar drugs that don ’t contain carcinogens. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 16, 2019 Category: Pharmaceuticals Source Type: news

Pancho Billa death leads to $5K in donations to Roswell Park
Buffalo Bills fans around the world have followed the story of uber-fan Ezra Castro (better known as Pancho Billa) as he battled cancer from his home in Texas. Castro’s death this week has been followed by a viral campaign to turn bad to good, with hundreds of followers making donations in his name to Roswell Park Comprehensive Cancer Center. Within just one day, the Buffalo hospital received 160 donations totaling more than $5,000 from individuals in 35 states and three countries. Those donations… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 15, 2019 Category: Biotechnology Authors: Tracey Drury Source Type: news

Pancho Billa death leads to $5K in donations to Roswell Park
Buffalo Bills fans around the world have followed the story of uber-fan Ezra Castro (better known as Pancho Billa) as he battled cancer from his home in Texas. Castro’s death this week has been followed by a viral campaign to turn bad to good, with hundreds of followers making donations in his name to Roswell Park Comprehensive Cancer Center. Within just one day, the Buffalo hospital received 160 donations totaling more than $5,000 from individuals in 35 states and three countries. Those donations… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 15, 2019 Category: Pharmaceuticals Authors: Tracey Drury Source Type: news

Amgen Showcases Oncology Pipeline At ASCO 2019
Data From Largest Oncology Pipeline in Company's History First-in-Human Data Evaluating Investigational AMG 510, the First KRASG12C Inhibitor to Reach Clinical Stage, in Solid Tumors Potential Versatility of BiTE® Immuno-oncology Platform Reinforced With Phase 1 Asset Updates THOUSAND OAKS, Calif., May 15, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that data from its oncology pipeline will be presented at the 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 31-June 4, 2019. Seven investigational assets will be featured across a range of hematologic malignan...
Source: Amgen News Release - May 15, 2019 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Less fat, more fruit may cut risk of dying of breast cancer
A large experiment finds that trimming dietary fat and eating more fruits and vegetables may lower a woman's risk of dying of breast cancer (Source: ABC News: Health)
Source: ABC News: Health - May 15, 2019 Category: Consumer Health News Tags: Health Source Type: news

Alpelisib Nearly Doubles PFS in PIK3-Mutated Breast Cancer Alpelisib Nearly Doubles PFS in PIK3-Mutated Breast Cancer
A novel PIK3 inhibitor combined with fulvestrant nearly doubled progression- free survival (PFS) in PIK3CA-mutated breast cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 15, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

A Low-Fat Diet May Lower the Risk of Dying from Breast Cancer
In this study, volunteers were provided with dietary guidelines to follow about what to eat. “Until this study, we lacked any data from a prospective randomized control trial, which is the gold standard, for showing that a dietary approach really does reduce the risk of dying from breast cancer,” says Dr. Neil Iyengar, a medical oncologist at Memorial Sloan Kettering Cancer Center, who was not involved in the study. “Many of us who are proponents of considering diet and exercise in the cancer treatment plan are excited by this trial data because it is the first to show in a very robust way that we can imp...
Source: TIME: Health - May 15, 2019 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer embargoed study Source Type: news

Lower-fat diet reduces risk of dying from breast cancer, study says
Women who followed a lower-fat diet rich in fruits, vegetables and grains had a lower risk of dying from breast cancer than those on a higher-fat diet, according to results from a major new study rele... (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - May 15, 2019 Category: Consumer Health News Authors: Laurie McGinley Source Type: news

New data for larotrectinib show overall response rates of 94% in children and 76% in adults with TRK fusion cancer; clinical benefit demonstrated in patients with primary central nervous system tumors and brain metastases (for specialized target groups only)
In children with TRK fusion cancer (n=34), the overall response rate (ORR) was 94% and durable, with median duration of response (DOR) not reached / In adults with TRK fusion cancer (n=74), the ORR was 76% and durable, with median DOR not reached / In evaluable patients with brain metastases (n=5), ORR was 60% / Improvements in quality of life were shown with larotrectinib treatment in both children and adults / Majority of adverse events were grade 1 or 2, as reported in prior publications (Source: Bayer Company News)
Source: Bayer Company News - May 15, 2019 Category: Pharmaceuticals Source Type: news

As the @US_FDA celebrates National Women ’ s Health Week, we want to remind women that thermography should not be used in place of mammography to detect, diagnose, or screen for breast cancer. Find out more: https://go.usa.gov/xmyfW   #NWHWpic.twitter.com/EIMAfXMpZR
As the @US_FDA celebrates National Women’s Health Week, we want to remind women that thermography should not be used in place of mammography to detect, diagnose, or screen for breast cancer. Find out more: https://go.usa.gov/xmyfW  #NWHW pic.twitter.com/EIMAfXMpZR (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - May 15, 2019 Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news

FDA Okays Another Immunotherapy Plus TKI for Advanced RCC FDA Okays Another Immunotherapy Plus TKI for Advanced RCC
The FDA has approved avelumab in combination with the tyrosine kinase inhibitor (TKI) axitinib for the first-line treatment of advanced renal cell carcinoma (RCC).FDA Approvals (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 15, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Trans Women on Hormones Have More Breast Cancer
Researchers found that trans women on hormone therapy had a higher breast cancer risk than the general male population but lower than the general female population. (Source: WebMD Health)
Source: WebMD Health - May 15, 2019 Category: Consumer Health News Source Type: news

Yale study identifies how cancer drug inhibits DNA repair in cancer cells
According to Yale research, a cancer drug thought to be of limited use may be able to stop certain cancer cells from repairing their DNA in order to survive. (Source: Yale Science and Health News)
Source: Yale Science and Health News - May 15, 2019 Category: Universities & Medical Training Source Type: news

Do Some Animals Have The DNA To Prevent Cancer?
BOSTON (CBS) – Being overweight increases your risk of cancer, but it turns out this is not always the case in the rest of the animal kingdom. Whales, for example, rarely get cancer, and researchers from Northern Arizona University wanted to know why. Despite being big and blubbery, whales rarely develop or die from cancer, unlike humans and other mammals like cats and dogs. The same is true for elephants. To find out why, researchers studied the DNA of skin samples taken from a female humpback whale off the coast of Massachusetts. Her name is Salt, and scientists have been studying her for decades. They found that w...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 15, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Syndicated Local Cancer DNA Research Northern Arizona University Source Type: news

Married mother-of-two dies of terminal cancer two years after her husband passed away from ALS
John Sylvester, 44, died of ALS in June 2017, the same day that his wife, Tessie, 38, learned she had cancer. In May 2019, after a two-year battle, she passed away, leaving behind their two sons. (Source: the Mail online | Health)
Source: the Mail online | Health - May 15, 2019 Category: Consumer Health News Source Type: news

Low-Fat Diet Could Be a Weapon Against Breast Cancer
WEDNESDAY, May 15, 2019 -- Health experts have long touted the benefits of a low-fat diet for preventing heart disease, but now a large study suggests it might do the same against breast cancer. Researchers found that eating low-fat foods reduced a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 15, 2019 Category: General Medicine Source Type: news

Gay and HIV positive men should be getting an 'anal Pap smear,' doctors suggest  
Anal cancer rates are have risen steeply, driven by HPV and, likely, wider acceptance of anal sex. Doctors at the University of California, San Francisco, think that an anal swab could prevent the disease. (Source: the Mail online | Health)
Source: the Mail online | Health - May 15, 2019 Category: Consumer Health News Source Type: news

AdaptImmune partners to advance promising cancer immunotherapies
Adaptimmune has entered into a collaboration and license agreement with Alpine Immune Sciences to advance Adaptimmune's next-generation SPEAR T-Cell products under development to treat a variety of cancers. Under the terms of the deal, Seattle-based Alpine Immune Sciences (NASDAQ: ALPN) will receive a $2 million upfront payment from Adaptimmune (NASDAQ: ADAP), which is based in Philadelphia and Oxfordshire, England. Alpine could earn up to an additional $288 million in development and commercializati on… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 15, 2019 Category: American Health Authors: John George Source Type: news

Azathioprine: Friend or Foe? Azathioprine: Friend or Foe?
A recent study presents new evidence for the association of azathioprine with increased risk of cutaneous malignancy, especially when combined with sunlight.The British Journal of Dermatology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 15, 2019 Category: Allergy & Immunology Tags: Dermatology Journal Article Source Type: news

Blood test could determine if a cancer is likely to spread - and how fast
The test, developed by researchers at the Royal Marsden in London, analyzes fragments of DNA that are shed by tumors into the blood. It accurately predicted spread in 47 patients. (Source: the Mail online | Health)
Source: the Mail online | Health - May 15, 2019 Category: Consumer Health News Source Type: news

Medical News Today: How whole-grain rye consumption can improve gut health
A new study looks to both humans and mice to understand how some whole grains can help maintain gut health and prevent diabetes and cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 15, 2019 Category: Consumer Health News Tags: Nutrition / Diet Source Type: news

Recent Immunotherapy Treatments for Metastatic Breast Cancer Recent Immunotherapy Treatments for Metastatic Breast Cancer
Kate M. O'Rourke looks at recent immunotherapy treatments for metastatic breast cancer that are proving effective.Medscape Oncology (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 15, 2019 Category: Allergy & Immunology Tags: Hematology-Oncology Article Source Type: news

Bowel cancer: Major signs and symptoms you must not ignore
BOWEL cancer is one of the most common types of cancer in the UK, with around 40,000 new cases being diagnosed every year. These are the major symptoms of bowel cancer you can not ignore and which mean you need to speak to your doctor. (Source: Daily Express - Health)
Source: Daily Express - Health - May 15, 2019 Category: Consumer Health News Source Type: news